APA (7th ed.) Citation

Ma, X., Tu, H., Ying, G., Wang, F., Shen, Y., Yu, Y., . . . Chen, Y. (2025). A preliminary study on the clinical value of simultaneous amplification and testing for tuberculosis (SAT-TB) for early therapeutic monitoring in multidrug-resistant/rifampicin-resistant tuberculosis. BMC Infectious Diseases, 25(1), 1. https://doi.org/10.1186/s12879-025-11917-z

Chicago Style (17th ed.) Citation

Ma, Xiaoqing, Han Tu, Guangzhi Ying, Fang Wang, Yaojie Shen, Yuxia Yu, Geng Chen, and Yuanyuan Chen. "A Preliminary Study on the Clinical Value of Simultaneous Amplification and Testing for Tuberculosis (SAT-TB) for Early Therapeutic Monitoring in Multidrug-resistant/rifampicin-resistant Tuberculosis." BMC Infectious Diseases 25, no. 1 (2025): 1. https://doi.org/10.1186/s12879-025-11917-z.

MLA (9th ed.) Citation

Ma, Xiaoqing, et al. "A Preliminary Study on the Clinical Value of Simultaneous Amplification and Testing for Tuberculosis (SAT-TB) for Early Therapeutic Monitoring in Multidrug-resistant/rifampicin-resistant Tuberculosis." BMC Infectious Diseases, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12879-025-11917-z.